Yu Xia - Director at Summit Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SMMT on Nasdaq
All Insider Reports
All Insider Reports

Yu Xia - trading volume in the past year for Summit Therapeutics Inc.

Holdings reported by Yu Xia for Summit Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 32,057,147 $600,750,934 $18.74 21 Oct 2025 Akeso, Inc.
Stock Option (right to buy) 35,000 $49,921 $9.18 02 Jan 2026 Direct Common Stock

Transactions reported by Yu Xia for Summit Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.